Purpose This project sought to test the utility of post-delivery human placenta (HP) as a vascular model for liquid embolic agent (LEA) simulation, along with adjunctive techniques.
Materials and methods Twelve LEA injections were performed under fluoroscopy in HP with two reflux control methods: dual lumen ‘mini’ balloon-catheter (n=9); and injection after proximal nBCA plug formation through a second microcatheter (‘pressure cooker’) (n=3). Measured outcomes included liquid embolic agent (LEA) advancement and reflux. Reflux was categorized into three grades: grade 0=no reflux; grade 1=occlusion of side branches without reflux beyond the balloon or plug; and grade 2=reflux beyond the balloon or plug.
Results Simulation success was greater when a balloon was used rather than with a nBCA plug (89% vs 33%, P=0.054). In eight successful balloon-assisted injections, the reflux grades were: 50% grade 0; 12.5% grade 1; and 37.5% grade 2. The one successful nBCA plug injection had grade 2 reflux. All grade 2 balloon injections occurred when the balloon was positioned across a vessel bifurcation.
Conclusions HP provides excellent simulation for liquid embolic agents with a dual lumen balloon catheter.
- liquid embolic material
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors DKL conceived the study. HO, JC, and DKL executed this study. HO performed acquisition and analysis of data for work and drafted it. DMH reviewed the manuscript critically and revised it. All authors reviewed the final version of the manuscript.
Funding Medtronic, Microvention Terumo, Asahi Intec, Codman, and Stryker supported this study by donating the endovascular devices.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.